2013 American Transplant Congress
Proton Beam Radiotherapy (PBRT) Versus Tace for Hepatocellular Carcinoma (HCC) Prior to Liver Transplantation (LT)
We retrospectively analyzed our long term experience on the use of PBRT versus TACE for downstaging or bridge therapy of HCC prior to LT. Methods:…2013 American Transplant Congress
Risk of Transmission of Cancer from Solid Organ Donors in the U.S
National Cancer Institute, Rockville, MD
Background: Transmission (TX) of cancer is a rare but life-threatening complication of transplantation. Most cancers preclude donation, but some may be missed if an accurate…2013 American Transplant Congress
Efficacy and Safety of Calcineurin Inhibitor Withdrawal in Living Donor Kidney Transplantation with Older Donors
Background: Living donor kidney transplantation recipients with older donors often have lower GFR than whom with young donors after transplantation. Calcineurin inhibitor (CNI) may cause…2013 American Transplant Congress
Long-Term Exposure to Belatacept in Recipients of Extended Criteria Donor Kidneys
Background: Kidney transplant recipients treated with belatacept-based immunosuppression in the BENEFIT-EXT study had comparable patient and graft survival and better renal function vs a cyclosporine-based…2013 American Transplant Congress
Triple Non-Steroidal Maintenance Therapy in a Cohort of Kidney Transplanted Children
Paediatric Nephrology Department, Hospital Vall d'Hebron, Barcelona, Spain
BACKGROUND:Calcineuric inhibitors (CNI) avoidance or dose reduction has been proposed in pediatric kidney transplant (KTx) recipients with nephrotoxicity or neurologic side effects. Combination of CNI,…2013 American Transplant Congress
Medication Non-Adherence after Kidney Transplantation: A Qualitative Study Using Depth Interviews of Adherent and Non-Adherent Patients
Background: Non-adherence to immunosuppressive medications is an important cause of allograft loss after kidney transplant. To examine factors influencing medication adherence in adult kidney transplant…2013 American Transplant Congress
Oral Ribavirin Therapy for Respiratory Syncytial Virus Infections in Moderately to Severely Immunocompromised Patients
BackgroundRespiratory syncytial virus (RSV) can be fatal in immunocompromised patients. Aerosolized ribavirin is used for treatment but it is costly, teratogenic, and inconvenient. We aimed…2013 American Transplant Congress
Utilization of Kidneys from Donors after Circulatory Death in China: An Initial Report from a Single Center
In 2007, a landmark decision that is supported by the international transplant community, the Chinese national government has established regulations to gradually abolish the use…2013 American Transplant Congress
Outcomes of Switching to Belatacept from a Calcineurin Inhibitor in Kidney Transplant Recipients: 3 Year Results from the Long-Term Extension of a Phase II Study
Introduction: There remains a need for immunosuppressive agents which offer long-term preservation of renal function and an acceptable safety profile in the switch setting. Here…2013 American Transplant Congress
Polyoma BK-Virus-Specific T Cells as a Surrogate Marker for Polyomavirus-Associated Nephropathy after Pediatric Kidney Transplantation
After kidney transplantation (KTx) immunosuppressive therapy causes impaired cellular immune defense resulting in increased risk of polyomavirus-associated nephropathy (PVAN). Prognostic markers for the outcome of…
- « Previous Page
- 1
- …
- 133
- 134
- 135
- 136
- 137
- …
- 178
- Next Page »